Patent Assignment
Reel/Frame 022505/0620
Amended and Restated Assginment of 50% Interest to Enzon Pharmaceuticals, Inc. Effective July 26, 2006
Recorded: 2009-04-05
Pages: 3
Assignor
SANTARIS PHARMA A/S
Executed: 2009-03-25
Assignee
ENZON PHARMACEUTICALS, INC.
685 ROUTE 202/206, BRIDGEWATER, NEW JERSEY, 08807
Covered Property
(1)
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 6, 2006
From: WESTERGAARD, MAJKEN; THRUE, CHARLOTTE A.; RASMUSSEN, FRANK W.; HANSEN, HENRIK F.
To: SANTARIS PHARMA A/S
Reel/Frame 018088/0007 →
Assignment of Assignor's Interest
Jul 23, 2007
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019589/0140 →
Assignment of Assignor's Interest
Sep 21, 2007
From: SANTARIS PHARMA A/S
To: ENZON, INC.
Reel/Frame 019861/0738 →
Assignment of Assignor's Interest
Aug 25, 2014
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 033600/0791 →
Merger and Change of Name
Apr 13, 2015
From: SANTARIS PHARMA A/S; ROCHE INNOVATION CENTER COPENHAGEN A/S
To: ROCHE INNOVATION CENTER COPENHAGEN A/S
Reel/Frame 035421/0435 →
Corrective Assignment to Correct Schedule of the Executed Inside the Assignment Document. Previously Recorded at Reel: 033600 Frame: 0791. Assignor(S) Hereby Confirms the Assignment.
Feb 16, 2016
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 037847/0121 →